Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.22 +0.61 (+0.82%)
As of: Oct 1, 2026 · 3:41 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Tax Provisions (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International's Tax Provisions was $5.71 million in Q2 2026, up 13.2% from $5.05 million a year earlier but down 43.4% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Tax Provisions (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Kiniksa Pharmaceuticals International's Tax Provisions was $33.59 million through Jun 30, 2026, up 254.7% year-over-year; for FY2025, it came in at $29.86 million, up 324.1% from FY2024.

  • Tax Provisions shows a five-year compound annual growth rate of 42.1% (FY2020 to FY2025).
  • In earlier years, Tax Provisions was $7.04 million in FY2024, -$30.74 million in FY2023, -$172.34 million in FY2022 and $1.39 million in FY2021 (-73.1%).
  • Quarterly Tax Provisions has moved between -$177.36 million (Q3 2022) and $10.09 million (Q1 2026) over five years.
  • Compared with a year earlier, Tax Provisions was higher in five of the last six quarters, with growth averaging 34.1%.
  • The best year-over-year quarter for Tax Provisions over five years was Q1 2022 (growth of 816.7%); the worst was Q4 2021 (a decline of 64.6%).
  • Per Business Quant data, KNSA's Tax Provisions in the three quarters before Q2 2026 was $10.09 million (Q1 2026), $9.07 million (Q4 2025) and $8.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Kiniksa Pharmaceuticals International 11.64 Bn 10.38 Bn 220.03 Mn 5.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.71 Mn
Mar 31, 2026 10.09 Mn
Dec 31, 2025 9.07 Mn
Sep 30, 2025 8.72 Mn
Jun 30, 2025 5.05 Mn
Mar 31, 2025 7.03 Mn
Dec 31, 2024 -8.09 Mn
Sep 30, 2024 5.49 Mn
Jun 30, 2024 6.21 Mn
Mar 31, 2024 3.43 Mn
Dec 31, 2023 -22.79 Mn
Sep 30, 2023 5.36 Mn
Jun 30, 2023 -16.21 Mn
Mar 31, 2023 2.91 Mn
Dec 31, 2022 2.38 Mn
Sep 30, 2022 -177.36 Mn
Jun 30, 2022 716,000.00
Mar 31, 2022 1.93 Mn
Dec 31, 2021 279,000.00
Sep 30, 2021 -118,000.00
API Access

Kiniksa Pharmaceuticals International Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=KNSA&period=max&api_key=YOUR_API_KEY